Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Director departure
Asset disposition
Inv. presentation
Quarterly results
Credit agrmnt [a]
|
|
Xtant Medical Holdings, Inc. (XTNT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/18/2023 |
8-K
| Quarterly results |
| 08/10/2023 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Fin... |
| 08/09/2023 |
8-K
| Other Events Interactive Data |
| 08/03/2023 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 56.7% stake in Xtant Medical Holdings, Inc. |
| 08/01/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/01/2023 |
8-K
| Quarterly results |
| 07/28/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 07/28/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/28/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/28/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/28/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/28/2023 |
8-K
| Quarterly results |
| 07/28/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"CERTIFICATE OF AMENDMENT OF THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF XTANT MEDICAL HOLDINGS, INC. Xtant Medical Holdings, Inc., a corporation organized and existing under and by virtue of the laws of the State of Delaware , pursuant to the provisions of the General Corporation Law of the State of Delaware , DOES HEREBY CERTIFY that: FIRST: The Board of Directors of the Corporation , at a meeting held on April 26, 2023, duly adopted resolutions setting forth a proposed amendment of the Amended and Restated Certificate of Incorporation of the Corporation, as amended, declaring said amendment to be advisable and proposing that said amendment be submitted to the stockholders of the Corporation for their consideration and approval. The resolution setting forth the proposed amend...",
"CERTIFICATE OF AMENDMENT OF THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF XTANT MEDICAL HOLDINGS, INC. Xtant Medical Holdings, Inc., a corporation organized and existing under and by virtue of the laws of the State of Delaware , pursuant to the provisions of the General Corporation Law of the State of Delaware , DOES HEREBY CERTIFY that: FIRST: The Board of Directors of the Corporation , at a meeting held on April 26, 2023, duly adopted resolutions setting forth a proposed amendment of the Amended and Restated Certificate of Incorporation of the Corporation, as amended, declaring said amendment to be advisable and proposing that said amendment be submitted to the stockholders of the Corporation for their consideration and approval. The resolution setting forth the proposed amend...",
"CERTIFICATE OF AMENDMENT OF THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF XTANT MEDICAL HOLDINGS, INC. Xtant Medical Holdings, Inc., a corporation organized and existing under and by virtue of the laws of the State of Delaware , pursuant to the provisions of the General Corporation Law of the State of Delaware , DOES HEREBY CERTIFY that: FIRST: The Board of Directors of the Corporation , at a meeting held on April 26, 2023, duly adopted resolutions setting forth a proposed amendment of the Amended and Restated Certificate of Incorporation of the Corporation, as amended, declaring said amendment to be advisable and proposing that said amendment be submitted to the stockholders of the Corporation for their consideration and approval. The resolution setting forth the proposed amend...",
"XTANT MEDICAL HOLDINGS, INC. 2023 EQUITY INCENTIVE PLAN",
"NOTICE OF OPTION GRANT UNDER THE XTANT MEDICAL HOLDINGS, INC. 2023 equity INCENTIVE PLAN Xtant Medical Holdings, Inc., a Delaware corporation , pursuant to the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan , hereby grants to the individual named below a Non-Statutory Stock Option to purchase from the Company that number of shares of Common Stock , as indicated below at an exercise price per Share equal to the amount as indicated below . The Option is subject to all of the terms and conditions set forth in this Notice of Option Grant , in the Option Award Agreement attached hereto , and in the Plan, all of which are incorporated herein in their entirety. Capitalized terms not otherwise defined herein will have the meaning set forth in the Plan. This Option grant has been made as o...",
"NOTICE OF RESTRICTED STOCK UNIT GRANT UNDER THE XTANT MEDICAL HOLDINGS, INC. 2023 equity INCENTIVE PLAN Xtant Medical Holdings, Inc., a Delaware corporation , pursuant to the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan , hereby grants to the individual named below the number of Restricted Stock Units set forth below . The Restricted Stock Units are subject to all of the terms and conditions set forth in this Notice of Restricted Stock Unit Grant , in the Restricted Stock Unit Award Agreement attached hereto , and in the Plan, all of which are incorporated herein in their entirety. Capitalized terms not otherwise defined herein will have the meaning set forth in the Plan. This Restricted Stock Units grant has been made as of the grant date indicated below, which shall be referre...",
"NOTICE OF RESTRICTED STOCK UNIT GRANT UNDER THE XTANT MEDICAL HOLDINGS, INC. 2023 equity INCENTIVE PLAN Xtant Medical Holdings, Inc., a Delaware corporation , pursuant to the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan , hereby grants to the individual named below the number of Restricted Stock Units set forth below . The Restricted Stock Units are subject to all of the terms and conditions set forth in this Notice of Restricted Stock Unit Grant , in the Restricted Stock Unit Award Agreement attached hereto , and in the Plan, all of which are incorporated herein in their entirety. Capitalized terms not otherwise defined herein will have the meaning set forth in the Plan. This Restricted Stock Units grant has been made as of the grant date indicated below, which shall be referre...",
"NOTICE OF DEFERRED STOCK UNIT GRANT UNDER THE XTANT MEDICAL HOLDINGS, INC. 2023 equity INCENTIVE PLAN Xtant Medical Holdings, Inc., a Delaware corporation , pursuant to the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan , hereby grants to the individual named below the number of Deferred Stock Units set forth below . The Deferred Stock Units are subject to all of the terms and conditions set forth in this Notice of Deferred Stock Unit Grant , in the Deferred Stock Unit Award Agreement attached hereto , and in the Plan, all of which are incorporated herein in their entirety. Capitalized terms not otherwise defined herein will have the meaning set forth in the Plan. This Deferred Stock Units grant has been made as of the grant date indicated below, which shall be referred to as the ..." |
|
| 07/14/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 07/14/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/12/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 07/11/2023 |
S-3/A
| Form S-3/A - Registration statement under Securities Act of 1933: [Amend] |
| 07/11/2023 |
8-K
| Quarterly results |
| 07/07/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 07/03/2023 |
8-K
| Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Unregistered Sales of Equity Secur...|
Docs:
|
"SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of July 3, 2023, among Xtant Medical Holdings, Inc., a Delaware corporation , and each purchaser identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an exemption from the registration requirements under Section 5 of the Securities Act of 1933, as amended contained in Section 4 thereof and/or Regulation D thereunder as to the issuance of the securities of the Company hereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement. NOW, THEREFORE, IN CONSIDERATION of the mutual coven...",
"Schedule 6.1 None. 2 Schedule 6.1 None. 3 Annex A Selling Stockholder Notice and Questionnaire The undersigned beneficial owner of common stock of [_______, a [________ corporation , understands that the Company has filed or intends to file with the Securities and Exchange Commission a registration statement for the registration and resale under Rule 415 of the Securities Act of 1933, as amended , of the Registrable Securities, in accordance with the terms of the Registration Rights Agreement to which this document is annexed. A copy of the Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement. Certain legal cons..." |
|
| 05/19/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 05/19/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits ...|
Docs:
|
"THIRD AMENDED AND RESTATED BYLAWS OF XTANT MEDICAL HOLDINGS, INC. Article I Meetings of Stockholders Section 1.1. Annual Meetings . If required by applicable law, an annual meeting of stockholders of Xtant Medical Holdings, Inc. shall be held for the election of directors either at such date, time and place, if any, either within or without the State of Delaware, or by means of remote communication, as may be designated by resolution of the Board of Directors of the corporation from time to time. Any other proper business may be transacted at the annual meeting. The corporation may postpone, reschedule, adjourn, recess or cancel any annual meeting of stockholders previously scheduled. Section 1.2. Special Meetings . Special meetings of stockholders for any purpose or purposes may be called..." |
|
| 05/18/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/16/2023 |
8-K/A
| Financial Statements and Exhibits Interactive Data|
Docs:
|
"CONSENT OF INDEPENDENT ACCOUNTING FIRM We consent to the incorporation by reference in Xtant Medical Holdings, Inc.’ s Registration Statements on Form S-3 , Form S-1 and on Form S-8 of our report dated May 16, 2023 with respect to the abbreviated financial statements of Surgalign SPV, Inc., which report appears in the Form 8-K/A of Xtant Medical Holdings, Inc. filed May 16, 2023. /s/ Plante & Moran, PLLC May 16, 2023 Denver, Colorado",
"SURGALIGN SPV, INC. ABBREVIATED FINANCIAL STATEMENTS",
"UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION On February 28, 2023, Xtant Medical Holdings, Inc., a Delaware corporation , entered into an Equity Purchase Agreement with Surgalign SPV, Inc. , a Delaware corporation and wholly owned subsidiary of Surgalign Spine Technologies, Inc., a Delaware corporation , Seller and Surgalign Holdings, Inc., a Delaware corporation, pursuant to which Xtant purchased all of the issued and outstanding shares of common stock of Surgalign SPV, which shares constituted all of the outstanding equity of Surgalign SPV, for an aggregate purchase price of $17.0 million in cash . The Company funded the purchase price with cash on hand and approximately $5.0 million of indebtedness incurred under its term loan. The closing contemplated by the Equity Purc..." |
|
| 05/05/2023 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 67.1% stake in Xtant Medical Holdings, Inc. |
| 05/04/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/04/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data|
Docs:
|
"XTANT MEDICAL HOLDINGS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS March 31, 2023 December 31, 2022 ASSETS Current Assets: Cash and cash equivalents $ 5,410 $ 20,507 Trade accounts receivable, net of allowance for credit losses and doubtful accounts of $621 and $515, respectively 11,902 10,853 Inventories 18,522 17,285 Prepaid and other current assets 753 673 Total current assets 36,587 49,318 Property and equipment, net 6,826 5,785 Right-of -use asset, net 1,269 1,380 Goodwill 7,639 3,205 Intangible assets, net 10,810 344 Other assets 185 197 Total Assets $ 63,316 $ 60,229 LIABILITIES & STOCKHOLDERS’ EQUITY Current Liabilities: Accounts payable $ 3,421 $ 3,490 Accrued liabilities 5,595 5,496 Current portion of lease liability 473 458 Current portion of finance lease obligations 63 62 Line..." |
|
| 05/04/2023 |
8-K
| Quarterly results |
| 03/07/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/07/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data|
Docs:
|
"XTANT MEDICAL HOLDINGS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS As of December 31, 2022 As of December 31, 2021 ASSETS Current Assets: Cash and cash equivalents $ 20,298 $ 18,243 Restricted cash 209 144 Trade accounts receivable, net of allowance for credit losses of $515 and doubtful accounts of $552, respectively 10,853 7,154 Inventories 17,285 17,945 Prepaid and other current assets 673 844 Total current assets 49,318 44,330 Property and equipment, net 5,785 5,212 Right-of -use asset, net 1,380 1,258 Other assets 197 287 Intangible assets, net 344 400 Goodwill 3,205 3,205 Total Assets $ 60,229 $ 54,692 LIABILITIES & STOCKHOLDERS’ EQUITY Current Liabilities: Accounts payable $ 3,490 $ 2,615 Accrued liabilities 5,496 4,349 Current portion of lease liability 458 462 Finance lease obilig..." |
|
| 03/01/2023 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financia...|
Docs:
|
"EQUITY PURCHASE AGREEMENT",
"TRANSITION SERVICES AGREEMENT AMONG SURGALIGN SPV, INC., SURGALIGN SPINE TECHNOLOGIES, INC., AND XTANT MEDICAL HOLDINGS, INC. DATED FEBRUARY 28, 2023",
"RECITALS A. Agent, Lenders, and the Credit Parties have entered into that certain Credit, Security and Guaranty Agreement, dated as of May 6, 2021 , dated as of March 7, 2022, and by that certain Amendment No. 2 to Credit, Security and Guaranty Agreement , dated as of October 27, 2022 the “Existing Credit Agreement” and as amended hereby and as it may be further amended, modified, supplemented and restated from time to time, the “Credit Agreement”), pursuant to which the Lenders have agreed to make certain advances of money and to extend certain financial accommodations to Borrowers in the amounts and manner set forth in the Credit Agreement. B. The Credit Parties have requested, and Agent and all Lenders have agreed, to amend certain provisions of the Existing Credit Agreement in order to...",
"RECITALS A. Agent, Lenders, and the Credit Parties have entered into that certain Credit, Security and Guaranty Agreement, dated as of May 6, 2021 , dated as of March 7, 2022, and by that certain Amendment No. 2 to Credit, Security and Guaranty Agreement , dated as of October 27, 2022 the “Existing Credit Agreement” and as amended hereby and as it may be further amended, modified, supplemented and restated from time to time, the “Credit Agreement”), pursuant to which the Lenders have agreed to make certain advances of money and to extend certain financial accommodations to Borrowers in the amounts and manner set forth in the Credit Agreement. B. The Credit Parties have requested, and Agent and all Lenders have agreed, to amend certain provisions of the Existing Credit Agreement, all in acc...",
"Xtant Medical Acquires Coflex® Product Line from Surgalign for $17 Million" |
|
| 02/14/2023 |
SC 13G/A
| Altium Capital Management LP reports a 5.7% stake in Xtant Medical Holdings, Inc. |
| 02/01/2023 |
8-K
| Quarterly results |
| 01/09/2023 |
8-K
| Quarterly results |
|
|
|